1. Icos Corporation (34 from 164 patents)

2. Other (3 from 832,680 patents)

3. Prolinx Incorporated (3 from 30 patents)

4. Luitpold Pharmaceuticals, Inc. (2 from 19 patents)

5. Algomedix, Inc. (2 from 2 patents)

6. Neumedics (1 from 1 patent)

1. 10906907 - Tert-butyl (s)-(1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl)carbamate precursor of a quinazolinone inhibitor of human phosphatidylinositol 3-kinase delta and a process for preparing thereof

2. 10695349 - Inhibitors of human phosphatidylinositol 3-kinase delta

3. 10428049 - TRPA1 modulators

4. 10398695 - Inhibitors of human phosphatidylinositol 3-kinase delta

5. 10336756 - (S)-2-(1-aminopropyl)-5-fluoro-3-phenylquinazolin-4(3H)-one precursor of a quinazolinone as inhibitor of human phosphatidylinositol 3-kinase delta

6. 10010550 - Inhibitors of human phosphatidylinositol 3-kinase delta

7. 9951046 - TRPA1 modulators

8. 9896422 - Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits

9. 9573912 - Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits

10. 9487772 - Inhibitors of human phosphatidylinositol 3-kinase delta

11. 9168265 - Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits

12. 9149477 - 5-fluoro-3-phenyl-2-[1-(9h-purin-6-ylamino)propyl]-3h-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta

13. 8993583 - 5-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta

14. 8980901 - 5-fluoro-3-phenyl-2[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta

15. 8779131 - 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)-ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta